Paradigm Capital Management Inc Bausch Health Companies Inc. Transaction History

Paradigm Capital Management Inc

  • $2.21 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022
BUY
$7.06 - $23.63 $141,200 - $472,600
20,000 Added 100.0%
40,000 $334,000
Q1 2021

May 05, 2021
SELL
$21.37 - $34.38 $21,370 - $34,380
-1,000 Reduced 4.76%
20,000 $635,000
Q4 2020

Jan 20, 2021
BUY
$15.31 - $21.12 $321,510 - $443,520
21,000 New
21,000 $437,000

Others Institutions Holding BHC

# of Institutions
254
Shares Held
253M
Call Options Held
5.53M
Put Options Held
16.5M
View Full List

About Bausch Health Companies Inc.

BHC Quotes by TradingView
  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.7B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Paradigm Capital Management Inc Portfolio

Follow Paradigm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email